167 related articles for article (PubMed ID: 8055448)
1. Myxoid liposarcoma. Experience with chemotherapy.
Patel SR; Burgess MA; Plager C; Papadopoulos NE; Linke KA; Benjamin RS
Cancer; 1994 Aug; 74(4):1265-9. PubMed ID: 8055448
[TBL] [Abstract][Full Text] [Related]
2. Myxoid malignant fibrous histiocytoma: experience with chemotherapy.
Patel SR; Plager C; Papadopoulos NE; Benjamin RS
Am J Clin Oncol; 1995 Dec; 18(6):528-31. PubMed ID: 8526198
[TBL] [Abstract][Full Text] [Related]
3. Extraskeletal myxoid chondrosarcoma. Long-term experience with chemotherapy.
Patel SR; Burgess MA; Papadopoulos NE; Linke KA; Benjamin RS
Am J Clin Oncol; 1995 Apr; 18(2):161-3. PubMed ID: 7900708
[TBL] [Abstract][Full Text] [Related]
4. Myxoid liposarcoma metastatic to the thyroid gland: a case report and literature review.
Tysome JR; Sandison A; Clarke PM
J Laryngol Otol; 2006 Jun; 120(6):511-3. PubMed ID: 16563196
[TBL] [Abstract][Full Text] [Related]
5. [Treatment and prognosis of stage IV alveolar soft part sarcoma].
Zhao J; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):932-6. PubMed ID: 23336381
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy in adult desmoid tumors.
Patel SR; Evans HL; Benjamin RS
Cancer; 1993 Dec; 72(11):3244-7. PubMed ID: 8242548
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
Edmonson JH; Petersen IA; Shives TC; Mahoney MR; Rock MG; Haddock MG; Sim FH; Maples WJ; O'Connor MI; Gunderson LL; Foo ML; Pritchard DJ; Buckner JC; Stafford SL
Cancer; 2002 Feb; 94(3):786-92. PubMed ID: 11857314
[TBL] [Abstract][Full Text] [Related]
8. Treatment results obtained in metastatic soft-tissue sarcoma with a combination of doxorubicin and dacarbazine or doxorubicin and ifosfamide.
Weh HJ; Agarwal K; Zornig C; Schwarz R; Dietel M; Hossfeld DK
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S189-93. PubMed ID: 8453696
[TBL] [Abstract][Full Text] [Related]
9. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
[TBL] [Abstract][Full Text] [Related]
10. The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma.
Eilber FC; Eilber FR; Eckardt J; Rosen G; Riedel E; Maki RG; Brennan MF; Singer S
Ann Surg; 2004 Oct; 240(4):686-95; discussion 695-7. PubMed ID: 15383796
[TBL] [Abstract][Full Text] [Related]
11. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
12. Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
Elias A; Ryan L; Sulkes A; Collins J; Aisner J; Antman KH
J Clin Oncol; 1989 Sep; 7(9):1208-16. PubMed ID: 2504890
[TBL] [Abstract][Full Text] [Related]
13. A 15-year experience with chemotherapy of patients with paraganglioma.
Patel SR; Winchester DJ; Benjamin RS
Cancer; 1995 Oct; 76(8):1476-80. PubMed ID: 8620426
[TBL] [Abstract][Full Text] [Related]
14. Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institution.
Pisters PW; Patel SR; Varma DG; Cheng SC; Chen NP; Nguyen HT; Feig BW; Pollack A; Pollock RE; Benjamin RS
J Clin Oncol; 1997 Dec; 15(12):3481-7. PubMed ID: 9396401
[TBL] [Abstract][Full Text] [Related]
15. Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma.
Casper ES; Gaynor JJ; Harrison LB; Panicek DM; Hajdu SI; Brennan MF
Cancer; 1994 Mar; 73(6):1644-51. PubMed ID: 8156491
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
[TBL] [Abstract][Full Text] [Related]
17. Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study.
Zalupski M; Metch B; Balcerzak S; Fletcher WS; Chapman R; Bonnet JD; Weiss GR; Ryan J; Benjamin RS; Baker LH
J Natl Cancer Inst; 1991 Jul; 83(13):926-32. PubMed ID: 2067035
[TBL] [Abstract][Full Text] [Related]
18. Liposarcoma: patterns of tumor differentiation following induction chemotherapy.
Bui NB; Coindre JM; Maree D; Trojani M
Oncology; 1984; 41(3):170-3. PubMed ID: 6427719
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with doxorubicin, dacarbazine, and ifosfamide in advanced adult soft tissue sarcoma. Canadian Sarcoma Group--National Cancer Institute of Canada Clinical Trials Group.
Bramwell V; Quirt I; Warr D; Verma S; Young V; Knowling M; Eisenhauer E
J Natl Cancer Inst; 1989 Oct; 81(19):1496-9. PubMed ID: 2778839
[TBL] [Abstract][Full Text] [Related]
20. [Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
Li EX; Zhang YT; Shang JT; Xu Z; Geng Y; Li SM; Shi F; Wu YY
Ai Zheng; 2006 Aug; 25(8):1048-51. PubMed ID: 16965692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
